Allograft survival in patients receiving anticonvulsant medications

Steven Wassner, M. H. Malekzadeh, A. J. Pennisi, R. B. Ettenger, C. H. Uittenbogaart, R. N. Fine

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The use of phenobarbital and diphenylhydantoin in transplant recipients is associated with reduced cadaver allograft survival when compared to transplant recipients not receiving anticonvulsant medication. An attempt was made to overcome the adverse effect on allograft survival by either discontinuing the anticonvulsants (2 patients) or maintaining the dose of prednisone at >1 mg/kg/day (2 patients). Discontinuation of phenobarbital was successful after transplantation, with subsequent stabilization of allograft function. Of the 2 patients receiving >1 mg/kg/day of prednisone, renal function is normal in 1 patient; however, the second is undergoing chronic rejection. Neither patient appears cushingoid. Anticonvulsant medication should be discontinued prior to transplantation. If the patient has an active seizure disorder, prednisone dosage should be maintained at a higher level.

Original languageEnglish (US)
Pages (from-to)293-297
Number of pages5
JournalClinical Nephrology
Volume8
Issue number1
StatePublished - Dec 1 1977

Fingerprint

Anticonvulsants
Allografts
Prednisone
Phenobarbital
Transplantation
Phenytoin
Cadaver
Epilepsy
Kidney
Transplant Recipients

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Wassner, S., Malekzadeh, M. H., Pennisi, A. J., Ettenger, R. B., Uittenbogaart, C. H., & Fine, R. N. (1977). Allograft survival in patients receiving anticonvulsant medications. Clinical Nephrology, 8(1), 293-297.
Wassner, Steven ; Malekzadeh, M. H. ; Pennisi, A. J. ; Ettenger, R. B. ; Uittenbogaart, C. H. ; Fine, R. N. / Allograft survival in patients receiving anticonvulsant medications. In: Clinical Nephrology. 1977 ; Vol. 8, No. 1. pp. 293-297.
@article{5d360aa8bdfc44d599c2e7ae7f4f6c59,
title = "Allograft survival in patients receiving anticonvulsant medications",
abstract = "The use of phenobarbital and diphenylhydantoin in transplant recipients is associated with reduced cadaver allograft survival when compared to transplant recipients not receiving anticonvulsant medication. An attempt was made to overcome the adverse effect on allograft survival by either discontinuing the anticonvulsants (2 patients) or maintaining the dose of prednisone at >1 mg/kg/day (2 patients). Discontinuation of phenobarbital was successful after transplantation, with subsequent stabilization of allograft function. Of the 2 patients receiving >1 mg/kg/day of prednisone, renal function is normal in 1 patient; however, the second is undergoing chronic rejection. Neither patient appears cushingoid. Anticonvulsant medication should be discontinued prior to transplantation. If the patient has an active seizure disorder, prednisone dosage should be maintained at a higher level.",
author = "Steven Wassner and Malekzadeh, {M. H.} and Pennisi, {A. J.} and Ettenger, {R. B.} and Uittenbogaart, {C. H.} and Fine, {R. N.}",
year = "1977",
month = "12",
day = "1",
language = "English (US)",
volume = "8",
pages = "293--297",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "1",

}

Wassner, S, Malekzadeh, MH, Pennisi, AJ, Ettenger, RB, Uittenbogaart, CH & Fine, RN 1977, 'Allograft survival in patients receiving anticonvulsant medications', Clinical Nephrology, vol. 8, no. 1, pp. 293-297.

Allograft survival in patients receiving anticonvulsant medications. / Wassner, Steven; Malekzadeh, M. H.; Pennisi, A. J.; Ettenger, R. B.; Uittenbogaart, C. H.; Fine, R. N.

In: Clinical Nephrology, Vol. 8, No. 1, 01.12.1977, p. 293-297.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Allograft survival in patients receiving anticonvulsant medications

AU - Wassner, Steven

AU - Malekzadeh, M. H.

AU - Pennisi, A. J.

AU - Ettenger, R. B.

AU - Uittenbogaart, C. H.

AU - Fine, R. N.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - The use of phenobarbital and diphenylhydantoin in transplant recipients is associated with reduced cadaver allograft survival when compared to transplant recipients not receiving anticonvulsant medication. An attempt was made to overcome the adverse effect on allograft survival by either discontinuing the anticonvulsants (2 patients) or maintaining the dose of prednisone at >1 mg/kg/day (2 patients). Discontinuation of phenobarbital was successful after transplantation, with subsequent stabilization of allograft function. Of the 2 patients receiving >1 mg/kg/day of prednisone, renal function is normal in 1 patient; however, the second is undergoing chronic rejection. Neither patient appears cushingoid. Anticonvulsant medication should be discontinued prior to transplantation. If the patient has an active seizure disorder, prednisone dosage should be maintained at a higher level.

AB - The use of phenobarbital and diphenylhydantoin in transplant recipients is associated with reduced cadaver allograft survival when compared to transplant recipients not receiving anticonvulsant medication. An attempt was made to overcome the adverse effect on allograft survival by either discontinuing the anticonvulsants (2 patients) or maintaining the dose of prednisone at >1 mg/kg/day (2 patients). Discontinuation of phenobarbital was successful after transplantation, with subsequent stabilization of allograft function. Of the 2 patients receiving >1 mg/kg/day of prednisone, renal function is normal in 1 patient; however, the second is undergoing chronic rejection. Neither patient appears cushingoid. Anticonvulsant medication should be discontinued prior to transplantation. If the patient has an active seizure disorder, prednisone dosage should be maintained at a higher level.

UR - http://www.scopus.com/inward/record.url?scp=0017711843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017711843&partnerID=8YFLogxK

M3 - Article

C2 - 328199

AN - SCOPUS:0017711843

VL - 8

SP - 293

EP - 297

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 1

ER -

Wassner S, Malekzadeh MH, Pennisi AJ, Ettenger RB, Uittenbogaart CH, Fine RN. Allograft survival in patients receiving anticonvulsant medications. Clinical Nephrology. 1977 Dec 1;8(1):293-297.